Harm, hype and evidence: ELSI research and policy guidance.


Autoria(s): Caulfield, T; Chandrasekharan, S; Joly, Y; Cook-Deegan, R
Data(s)

2013

Identificador

http://www.ncbi.nlm.nih.gov/pubmed/23534337

gm425

Genome Med, 2013, 5 (3), pp. 21 - ?

http://hdl.handle.net/10161/8934

http://hdl.handle.net/10161/8934

Relação

Genome Med

10.1186/gm425

Tipo

Journal Article

Cobertura

England

Resumo

There has been much investment in research on the ethical, legal and social issues (ELSI) associated with genetic and genomic research. This research should inform the development of the relevant policy. So far, much of the relevant policy - such as in the areas of patents, genetic testing and genetic discrimination - seems to be informed more by speculation of harm and anecdote than by available evidence. Although a quest for evidence cannot always be allowed to delay policy choice, it seems axiomatic to us that policy options are improved by the incorporation of evidence.

Formato

21 - ?

Idioma(s)

ENG